Exclusive: Teva, Mylan Eye Pfizer's Brazil Venture, Sources Say
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva prices EpiPen generic at $300, same price as Mylan generic-Business News , Firstpost
Teva loses Copaxone patent dispute case to Mylan in UK - Pharmaceutical Business review
Farmaceutico: Teva ci riprova con Mylan, verso rialzo offerta fino almeno a 43 mld $
Mylan: no all'offerta di Teva. A meno che non riveda il prezzo... - FarmaciaVirtuale.it
How Mylan tried to keep Teva from selling a generic EpiPen
Drugmaker Teva makes $40B bid for rival Mylan
Mylan surprises analysts, Teva with long-delayed Copaxone approvals | Fierce Pharma
How a Teva-Mylan deal will affect Indian pharma companies | Mint
タダラフィル(Tadalafil) Mylan社製の個人輸入はベストドラッグへ
Teva makes $40 billion offer for Mylan
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Teva's Generic EpiPen Will Cost As Much As Mylan's Generic | Time
Mylan makes hostile $31.2 billion Perrigo bid to thwart Teva | Mint
Generici, da Teva Opa su Mylan - Pharmaretail
US lawmakers push Mylan, Teva over drug pricing probe - www.israelhayom.com
Teva plans competitor for Mylan's EpiPen - Drug Delivery Business
Teva Makes Hostile Bid To Acquire Mylan
Teva Accuses Mylan of 'Desperate Attempt' to Suppress Bid - Drug Discovery and Development
In blow to Teva, UK court rules in favor of Copaxone patent challenge | The Times of Israel
FDA Approves Teva's Generic EpiPen As Stock Rises
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
With Teva Bid Off the Table, Mylan's Stock In 'Show-Me' Mode - WSJ
